These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9365190)

  • 21. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatase activity in breast tissue.
    Miller WR
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):783-90. PubMed ID: 1954167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of aromatase activity by methyl sulfonyl PCB metabolites in primary culture of human mammary fibroblasts.
    Heneweer M; van den Berg M; de Geest MC; de Jong PC; Bergman A; Sanderson JT
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):50-8. PubMed ID: 15589976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of aromatase and sulphatase in breast tumour cells.
    Purohit A; Wang DY; Ghilchik MW; Reed MJ
    J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6.
    Speirs V; Walton DS; Hall MC; Atkin SL
    Br J Cancer; 1999 Oct; 81(4):690-5. PubMed ID: 10574257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
    Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
    Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
    Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
    Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing aromatase activity in the breast.
    Miller WR; Mullen P
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):597-604. PubMed ID: 8386538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.
    O'Neill JS; Elton RA; Miller WR
    Br Med J (Clin Res Ed); 1988 Mar; 296(6624):741-3. PubMed ID: 3126957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases.
    O'Neill JS; Miller WR
    Br J Cancer; 1987 Nov; 56(5):601-4. PubMed ID: 3426923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2.
    Singh A; Purohit A; Ghilchik MW; Reed MJ
    Endocr Relat Cancer; 1999 Jun; 6(2):139-47. PubMed ID: 10731102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors.
    Reed MJ; Topping L; Coldham NG; Purohit A; Ghilchik MW; James VH
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):589-96. PubMed ID: 8476771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical importance of intratumoral aromatase.
    Miller WR; Mullen P; Telford J; Dixon JM
    Breast Cancer Res Treat; 1998; 49 Suppl 1():S27-32; discussion S33-7. PubMed ID: 9797015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages, estrogen and the microenvironment of breast cancer.
    Mor G; Yue W; Santen RJ; Gutierrez L; Eliza M; Berstein LM; Harada N; Wang J; Lysiak J; Diano S; Naftolin F
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):403-11. PubMed ID: 10030689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha.
    Macdiarmid F; Wang D; Duncan LJ; Purohit A; Ghilchick MW; Reed MJ
    Mol Cell Endocrinol; 1994 Dec; 106(1-2):17-21. PubMed ID: 7895904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Aromatase protein variants and drug interactions in breast cancer: a molecular docking approach.
    Setti A; Venugopal Rao V; Priyamvada Devi A; Pawar SC; Naresh B; Kalyan CS
    J Recept Signal Transduct Res; 2012 Aug; 32(4):225-9. PubMed ID: 22712891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aromatase activity and interleukin-6 production by normal and malignant breast tissues.
    Purohit A; Ghilchik MW; Duncan L; Wang DY; Singh A; Walker MM; Reed MJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3052-8. PubMed ID: 7559896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
    Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
    Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide inhibition of cytokine-stimulated aromatase activity in breast tissue fibroblasts.
    Parish D; Purohit A; Singh A; Rosankiewicz J; Ghilchik MW; Reed MJ
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):165-72. PubMed ID: 11850221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.